V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330003300 | 330001720 | 1.67 | 71.3 | Curative (C) | 2015-01-05 | 2015-01-19 | CETUXIMAB + RT | N | Y | 330012564 | CETUXIMAB + RT |
| 330003301 | 330006919 | 1.7 | 52.5 | Curative (C) | 2017-01-05 | 2017-01-06 | Cetuximab + Radiotherapy Load | N | N | 330012565 | CETUXIMAB + RT |
| 330003302 | 330001721 | 1.61 | 71.8 | Curative (C) | 2013-01-28 | 2013-02-09 | EW EuroEwing 2012 Arm A VIDE | 02 | N | 330012570 | EURO-EWING |
| 330003303 | 330001722 | 1.8 | 102 | Neo-adjuvant (N) | 2014-02-14 | 2014-02-14 | PAM x 2 post-surgery (cycles 3&4) | N | N | 330012571 | MAP |
| 330003304 | 330001723 | 1.55 | 71.8 | Curative (C) | 2014-08-15 | 2014-08-15 | OST Euramos 1 Closed Trial - AP | null | null | 330012576 | MAP |
| 330003305 | 330006920 | null | null | Not known (9) | 2016-07-31 | 2016-08-07 | CYCLOPHOSPHAMIDE + RITUXIMAB | N | N | 330012577 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330003306 | 330001724 | 1.67 | 83.9 | Curative (C) | 2015-03-21 | 2015-03-21 | Cetuximab + Radiotherapy Load | N | N | 330012582 | CETUXIMAB + RT |
| 330003307 | 330001725 | 1.59 | 110 | Adjuvant (A) | null | 2016-12-29 | CARBOPLATIN + FLUOROURACIL | N | N | 330012587 | CARBO + FLUOROURACIL |
| 330003308 | 330001725 | null | 89.999 | Curative (C) | 2017-07-09 | 2017-07-14 | MAP | N | N | 330012587 | MAP |
| 330003309 | 330001726 | 1.66 | 65.5 | Palliative (P) | null | 2015-08-04 | GemCarbo Days 1+8 | 02 | null | 330012589 | GEMCARBO |
| 330003310 | 330006922 | 1.75 | 73.7 | Palliative (P) | 2017-04-24 | 2017-04-29 | Carboplatin+Fluorouracil 4 or 5 day | null | null | 330012591 | CARBO + FLUOROURACIL |
| 330003311 | 330006922 | 1.88 | 70.5 | Disease modification (D) | 2016-04-13 | 2016-04-15 | CYCLOPHOSPHAMIDE + RITUXIMAB | 2 | N | 330012591 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330003312 | 330006922 | 1.69 | 36.2 | Curative (C) | 2017-05-18 | 2017-05-27 | OST Euramos 1 Closed Trial - AP | Y | N | 330012591 | MAP |
| 330003313 | 330006922 | 0 | null | Curative (C) | 2013-08-12 | 2013-08-27 | OST Euramos 1 Closed Trial - AP | null | null | 330012591 | MAP |
| 330003314 | 330001727 | 1.72 | 68.7 | Curative (C) | 2016-06-26 | 2016-07-09 | DA 3+8 | N | N | 330012600 | DA |
| 330003315 | 330006923 | 1.58 | 78.2 | null | 2017-04-26 | 2017-04-29 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 330012601 | CARBO + FLUOROURACIL |
| 330003316 | 330006923 | 1.63 | 53.5 | null | 2014-01-21 | 2014-01-28 | CVP R | N | N | 330012601 | CVP R |
| 330003317 | 330006923 | 1.71 | null | Palliative (P) | 2013-06-09 | 2013-06-17 | CAP | N | N | 330012601 | CAP |
| 330003318 | 330006923 | 1.71 | 73 | null | 2014-09-23 | 2014-09-23 | CETUXIMAB + RT | null | null | 330012601 | CETUXIMAB + RT |
| 330003319 | 330006923 | null | 62.2 | null | 2017-04-06 | 2017-04-06 | CETUXIMAB + RT | 02 | N | 330012601 | CETUXIMAB + RT |
| 330003320 | 330001728 | 1.64 | 40 | Neo-adjuvant (N) | 2015-09-21 | 2015-09-21 | EW EuroEwing 99 : VIDE | N | N | 330012609 | EURO-EWING |
| 330003321 | 330001728 | 1.72 | 0 | Curative (C) | 2016-06-20 | 2016-06-20 | CYTARABINE + DAUNORUBICIN | 1 | N | 330012609 | DA |
| 330003328 | 330001730 | 1.32 | 95.3 | Palliative (P) | 2017-12-18 | 2017-12-18 | CARBOPLATIN + FLUOROURACIL | 02 | N | 330012627 | CARBO + FLUOROURACIL |
| 330003329 | 330001731 | 1.85 | 94.8 | Curative (C) | 2015-11-25 | 2015-11-27 | EW EuroEwing 99 : VIDE | N | N | 330012628 | EURO-EWING |
| 330003330 | 330001732 | 1.74 | 61 | Adjuvant (A) | 2014-02-27 | 2014-04-20 | EURAMOS TRIAL | N | N | 330012629 | EURAMOS TRIAL |
| 330003331 | 330001733 | 1.68 | 38.5 | Neo-adjuvant (N) | 2014-03-04 | 2014-03-17 | EW EuroEwing 99 : VIDE | 02 | null | 330012634 | EURO-EWING |
| 330003332 | 330006926 | 1.64 | 52.9 | Curative (C) | 2017-04-13 | 2017-04-21 | CETUXIMAB | 2 | Y | 330012638 | CETUXIMAB |
| 330003333 | 330006926 | 1.91 | 71.7 | Palliative (P) | null | 2014-07-17 | CAP | N | N | 330012638 | CAP |
| 330003334 | 330001734 | 1.66 | 50 | Neo-adjuvant (N) | 2016-09-22 | 2016-09-22 | Dox + HD Mtx (post PAM) | null | null | 330012642 | DOXORUBICIN + HD MTX |
| 330003335 | 330001735 | 1.67 | 75.5 | Curative (C) | 2015-05-27 | 2015-06-21 | Cetuximab 7 day (Cycle 1) | 02 | Y | 330012646 | CETUXIMAB |
| 330003336 | 330001735 | 1.73 | 75.6 | Not known (9) | 2013-07-03 | 2013-07-06 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 330012646 | CISPLATIN + GEMCITABINE |
| 330003337 | 330001735 | 1.67 | 54.7 | null | null | 2013-12-19 | CVP R | Y | N | 330012646 | CVP R |
| 330003338 | 330001735 | 1.58 | 39 | Curative (C) | 2013-08-21 | 2013-08-28 | CVP R | 02 | N | 330012646 | CVP R |
| 330003339 | 330001735 | 1.8 | 90.7 | Palliative (P) | 2013-09-28 | 2013-10-07 | CYCLOPHOSPHAMIDE + RITUXIMAB | N | N | 330012646 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330003340 | 330001736 | 1.8 | 23 | Curative (C) | 2014-07-21 | 2014-07-27 | Cetuximab 7 day (Cycle 1) | 2 | Y | 330012653 | CETUXIMAB |
| 330003341 | 330001737 | 1.6 | 66 | Curative (C) | 2016-10-05 | 2016-10-05 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | null | 330012654 | CISPLATIN + GEMCITABINE |
| 330003342 | 330001738 | null | null | Curative (C) | null | 2015-08-08 | EURAMOS TRIAL | null | null | 330012662 | EURAMOS TRIAL |
| 330003343 | 330001738 | 1.8 | 78 | Neo-adjuvant (N) | 2015-05-22 | 2015-06-03 | EW EuroEwing 2012 Arm A VIDE | 02 | N | 330012662 | EURO-EWING |
| 330003344 | 330001739 | 1.64 | 57.8 | Adjuvant (A) | 2017-03-17 | 2017-03-17 | Cisplatin + Etoposide (3 day) | 02 | N | 330012664 | CISPLATIN + ETOPOSIDE |
| 330003345 | 330001739 | 1.65 | 67.6 | Curative (C) | 2013-11-10 | 2013-11-10 | CARBOPLATIN + FLUOROURACIL | N | null | 330012664 | CARBO + FLUOROURACIL |
| 330003346 | 330001739 | 0 | 65 | Palliative (P) | 2017-11-02 | 2017-11-08 | CAP | N | N | 330012664 | CAP |
| 330003347 | 330001739 | 1.83 | 124.8 | Palliative (P) | 2016-07-03 | 2016-07-08 | Cisplatin + Etoposide po&iv 3 day | N | N | 330012664 | CISPLATIN + ETOPOSIDE |
| 330003348 | 330001739 | 1.8 | 30 | Palliative (P) | null | 2013-07-14 | CYCLOPHOSPHAMIDE + RITUXIMAB | N | N | 330012664 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330003349 | 330001739 | null | 28.1 | Curative (C) | 2016-06-04 | 2016-06-10 | Cetuximab + Radiotherapy Load | 02 | Y | 330012664 | CETUXIMAB + RT |
| 330003350 | 330001739 | 1.6 | 84 | Palliative (P) | 2015-04-16 | 2015-04-16 | GemCarbo Days 1+8 | 02 | N | 330012664 | GEMCARBO |
| 330003351 | 330001740 | 1.88 | 113 | Palliative (P) | 2015-06-20 | 2015-06-25 | MAP | N | N | 330012680 | MAP |
| 330003352 | 330001740 | 1.73 | 78.7 | Curative (C) | 2014-03-01 | 2014-03-20 | Dox + HD Mtx (post PAM) | N | N | 330012680 | DOXORUBICIN + HD MTX |
| 330003353 | 330001741 | 1.84 | 77.4 | Neo-adjuvant (N) | 2017-01-30 | 2017-01-30 | Dox + HD Mtx (post PAM) | 2 | N | 330012684 | DOXORUBICIN + HD MTX |
| 330003354 | 330001741 | 1.84 | 72 | Palliative (P) | 2017-01-06 | 2017-01-31 | CAP | 02 | N | 330012684 | CAP |
| 330003355 | 330001741 | 1.76 | 58.9 | Neo-adjuvant (N) | 2014-10-30 | 2014-10-31 | CAP | Y | N | 330012684 | CAP |